Skip to main content

Closed

ABUS: Arbutus Biopharma Corp Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin80.8%

ROIC56.7%

Financially safe

Strong

Debt / equity0.02×

Interest coverage1798.5×

Current ratio54.26×

Valuation

Unrated

P/E ratio5.2×

Arbutus Biopharma Corp

ABUSNASDAQ·USD·Closed

Arbutus Biopharma Corp

ABUSNASDAQ·USD·Closed

$4.34

−1.59%

$4.34

−$0.07 (1.59%)

52W Range

51thpctl

Volume

0.60×avg

Mkt Cap

857.31MUSD

P/E

5.2TTM

Div Yield

–ann

52W Range

51thpctl

Volume

0.60×avg

Market Cap

857.31MUSD

P/E Ratio

5.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings